WHAT WE DO?

Argonaut Ventures provides funding, strategic advice, and technical expertise to early-stage companies to build, manage and monetize new businesses.

With over 10 years of direct experience in building Internet companies from the ground up, our goal is to create a portfolio of succesful companies, and share in the success of our clients.

ARGONAUT VENTURES NEWS

Argonaut Ventures NewsNews
News
Argonaut Ventures Funds Health and Medical News Start-Up, MedNews

San Francisco, May 17, 2007 — Argonaut Ventures has provided seed funding to MedNews, a comprehensive provider of aggregated health and medical news, commentary, press releases, and press-clipping services. The company's news portal, MedNews.com, is scheduled to launch in August 2007.

"MedNews provides tremendous opportunity to tap into the fast-growing area of health and medical information online," says Argonaut Ventures partner, Matthew Naythons. "The company has a strong team, and we're confident they can deliver cutting-edge information and services to healthcare consumers, medical professionals, and corporate users."

MedNews

MedNews.com will provide members with a personalized interface to health and medical news and information, as well as publishing tools for commenting on stories, and clipping and storage of personal news archives by topic.

The company has developed tools for MedNews edtorial staff to efficiently review and publish a large volume of health and medical information, as well as original feature stories from MedNews medical professional writers.

Readers will have control over which topics are presented on their personalized version of the site, as well as research tools for gathering, publishing, and categorizing and archiving stories for later reference.

According to Peter Goggin, an Argonaut Ventures partner, "As traditional newspapers and other media are seeing a loss of readership to new and varied sources of information, MedNews has stepped in to provide the next generation of media publishing and delivery tools. We're pleased to be supporting the company in its earliest stages of development."

For more information, Contact Argonaut Ventures.